| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 18, 2026 | Privacy by Design at Scale: The Engineering Constraints Reshaping How the Ad-Tech Industry Extracts Market Intelligence | Share
Share
Share
Share
Email
Global advertisers will spend close to $992 billion in 2025, with digital channels accounting for roughly $678.7 billion of that investment, and programmatic platforms now handling about 90% of all digital disp... |
| Mar 20, 2026 | Is AI ‘vibe coding’ too good to be true? | AI means companies can now ‘vibe code’ their own software products on the cheap – but they may soon discover the risks, writes Paul Armstrong
Corporate leaders are about to discover software has become dangerously easy to build. Artificial ... |
| Dec 18, 2025 | Diploi launches to bridge the development gap between vibe coding and production-ready software | Diploi launches to bridge the development gap between vibe coding and production-ready software
Thu, Dec 18, 2025 08:00 CET Report this content
Vibe coding enables faster experimentation and idea deployment, but many popular tools lack the ... |
| Jul 26, 2024 | Pharmaceutical stocks to watch for end of 2024 | Pharma stocks can be strong investments regardless of economic conditions, as this stability arises because the demand for medications and healthcare services remains steady, even when prices rise.
Pharmaceutical stocks tend to be more resi... |
| Mar 19, 2024 | Antibody Drug Conjugate Market Size, Share Latest Trends, Demand and Advancement by 2035 | Roots Analysis
The global antibody drug conjugate market size was estimated at USD 7.7 billion in 2023 to USD 23 billion by 2035, growing at a CAGR of 9.63%
MOHALI, PUNJAB, INDIA, March 19, 2024 /EINPresswire.com/ -- According to a recently... |
| Feb 9, 2023 | The biologics fill finish services market is projected to grow at a CAGR of 8.4%, till 2035, claims Roots Analysis | A number of biopharmaceutical companies are outsourcing their biologics fill finish operations, thereby, prompting stakeholders engaged in this domain to undertake several expansion initiatives to cater to the needs of clients around the gl... |
| Feb 8, 2023 | The bioavailability enhancement services market is projected to grow at an annualized rate of 11.12% during the period 2021-2035, claims Roots Analysis | The bioavailability enhancement process is known to be fraught with several challenges, including its time and cost intensive nature; given the expertise available with service providers to improve pharmacokinetic properties of novel molecu... |
| Nov 1, 2022 | The antiviral drugs market is anticipated to grow at a CAGR of 6.3% during the period 2022-2035, claims Roots Analysis | London, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of "Antiviral Drugs Market, 2022 – 2035" report to its list of offerings.
The recent COVID-19 pandemic has exposed the lack of effective antiviral... |
| Oct 27, 2022 | The adeno associated viral vector / AAV vector market is anticipated to grow at a CAGR of more than 10% by 2035, claims Roots Analysis | Given its low immunogenicity, diversified targets and ability to offer higher biosafety, an adeno associated viral vector / AAV vector is actively being evaluated for the development of various therapies for the treatment of chronic disease... |
| Oct 27, 2022 | The prefilled syringes market is anticipated to grow at sustained rate till 2035, claims Roots Analysis | The current demand for safer, easier to use administration technologies along with the industry’s efforts to reduce costs and increase efficiency are expected to drive the growth of the prefilled syringes market in the foreseen future
/EIN ... |
| Oct 11, 2022 | The viral vector, non-viral vector and gene therapy manufacturing market is projected to grow at a CAGR of ~15% till 2035, claims Roots Analysis | London, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of "Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market, 2022-2035" report to its list of offerings.
... |
| Oct 11, 2022 | The ADC contract manufacturing market is projected to grow at a CAGR of more than 13% till 2035, claims Roots Analysis | London, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of "ADC Contract Manufacturing Market (5th Edition), 2022-2035" report to its list of offerings.
In order to mitigate the challenges associated wi... |
| Sep 23, 2022 | New Report Details How Asia Came to Dominate the Plant-Based Meat Industry | 3 Mins Read
A new report published by the researchers at Roots Analysis details how the intellectual property for plant-based meat has grown more than three times over the last decade, jumping from 2,388 in 2012 to 7,126 this year. And lead... |
| Sep 16, 2022 | The AI-based drug discovery market is projected to grow at an annualized rate of 25%, during the period 2022-2035, claims Roots Analysis | Stakeholders in the pharmaceutical industry are currently exploring the implementation of artificial intelligence (AI) based tools to expedite drug discovery timelines, minimize attrition rates of candidates and reduce capital investments
R... |
| Aug 23, 2022 | The biosensors market focused on drug discovery and development is projected to grow at an annualized rate of 9% during the period 2022-2035, claims Roots Analysis | In recent years, the use of biosensors in drug discovery has been on the rise, driven by several technological advancements and the growing demand for inexpensive and effective techniques for analyzing potential drug candidates
/EIN News/ -... |
| Aug 23, 2022 | The biosensors market focused on drug discovery and development is projected to grow at an annualized rate of 9% during the period 2022-2035, claims Roots Analysis | London, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of "Biosensors Market: Focus on Drug Discovery and Drug Development, 2022 - 2035" report to its list of offerings.
A number of drug developers are... |
| Jul 27, 2022 | The gene therapy market is projected to be worth USD 17.3 billion in 2035, growing at a CAGR of 18%, during the period 2022-2035, claims Roots Analysis | Given the potential of gene therapies to permanently cure a diverse array of clinical conditions at the genetic level, the current pipeline is rapidly growing; a number of such therapies are currently being evaluated in late stages of devel... |
| Jul 5, 2022 | The novel cardiovascular drug delivery devices market is projected to grow at a CAGR of 9.3%, till 2035, claims Roots Analysis | Given the growing number of patients suffering from cardiovascular disorders and the high associated financial burden, cardiovascular drug eluting stents have emerged as a safe and efficient novel drug delivery device to assist in providing... |
| Jun 23, 2022 | The viral vaccine cell culture media market is projected to grow at a CAGR of 5.8%, during 2022-2035, claims Roots Analysis | The recent surge in demand for vaccines amidst the COVID-19 pandemic has served to facilitate a strong case for organizations to opt for cell culture media for the development and manufacturing of large quantities of vaccines
/EIN News/ -- ... |
| Jun 21, 2022 | The continuous manufacturing market is projected to grow at an annualized rate of 17.3% during the period 2022-2035, claims Roots Analysis | In comparison to batch production methods, continuous manufacturing is not only cost and time-efficient, but also enables reduction in energy and manpower requirement, footprint, process-related errors and product inconsistencies
/EIN News/... |
| Jun 7, 2022 | The container closure integrity testing services market is projected to grow at a CAGR of 7% till 2035, claims Roots Analysis | Patient safety is one of the critical aspects of pharmaceutical industry, which makes it imperative for drug manufacturers and packaging service providers to evaluate the integrity of drug formulations packed in various container closure sy... |
| May 26, 2022 | The opportunity within the lyophilization services market for biopharmaceuticals is projected to grow at an annualized rate of ~7%, till 2035, claims Roots Analysis | Characterized by a rapidly growing pipeline of biosimilars and novel biologics, and the existing challenges associated with lyophilization of biotherapeutics, stakeholders are increasingly relying on service providers offering multidiscipli... |
| May 18, 2022 | The singe-use upstream bioprocessing technology market is projected to grow at a CAGR of 12% till 2035, claims Roots Analysis | Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufacturing equipment to single-use upstream bioprocessing systems
/EIN News/ ... |
| May 3, 2022 | The subcutaneous formulation technologies market is anticipated to grow at a CAGR of 21.8%, till 2035, while the subcutaneous drug delivery systems market is anticipated to grow at a CAGR of over 40%, till 2035, claims Roots Analysis | Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought a paradigm shift in at-home healthcare, enabling users to administer medications without having to rely on medical professionals
/EIN News/... |
| Apr 7, 2022 | The peptide therapeutics contract API manufacturing market is anticipated to grow at an annualized rate of 13.6%, claims Roots Analysis | Given the inherent expertise of CMOs and CDMOs, they are believed to be capable of enabling reduction in product development timelines, significant cost-benefits, as well as provide peptide developers access to larger production capacities ... |
| Oct 14, 2020 | The global digital therapeutics market is projected to be worth over USD 8.9 billion by 2030, growing at a CAGR of 19.7%, claims Roots Analysis | |
| Oct 13, 2020 | The STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics, is anticipated to be worth over USD 2.8 billion by 2030, predicts Roots Analysis | |
| Sep 8, 2020 | Growing at an annualized rate of over 9%, the antibody discovery services market is projected to be worth USD 6.5 billion by 2030; the antibody discovery platforms market is estimated to be worth close to USD 6 billion by 2030: Roots Analysis | |
